Quick reference: retatrutide dosage chart This chart reflects the escalation schedule used in Phase 2 and Phase 3 clinical trials: Standard titration protocol (2mg start 12mg target) Alternative protocols by target dose Target: 8 mg maintenance Target: 4 mg maintenance Key principle: Start low, go slow
Our clinicians prefer to classify these medications as incretin mimetics, which include drugs that act as GLP-1s, GLP-1/GIPs, and others
Because many patients begin GLP-1 therapy alongside other medications or lifestyle changes, careful history-taking is critical
Special considerations for specific populations Not everyone approaches GLP-1 drops from the same starting point
Schedule a consultation today to learn how our physician-led Confident Body Program can help your child build a healthier metabolism and a healthier future
In addition to the possible health risks associated with the use of GLP-1 drugs, these therapies are associated with a high out-of-pocket cost for individuals who do not qualify for their use through insurance, such as those wanting to lose weight without falling into the obesity or diabetes categories
